NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









PharosBio

PharosBio

Private
CopenhagenHealthcare & Life Scienceshttps://pharos.bio/

Last Round

Convertible Debt

Dec 22, 2025

Est. Valuation

$67.74M

Total Funding Raised

$48.86M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PharosBio is a healthcare and life science software company that provides an autonomous AI platform for scientific research and data analysis.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, NLP & Conversational AI, Medical AI, Workflow Automation, Biotechnology

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

agentic AIdrug discoveryAI research platformAI agentsbiotech AIautonomous researchtranslational researchAI drug discoveryscientific workflow automationAI copilotusage-based SaaSbioinformaticsvibe codingAI lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PharosBio Comparables

Compare PharosBio with similar companies based on industry and business-model similarity.

PharosBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Causaly
79%
Convexia
79%
CellType
79%

PharosBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtDec 22, 2025
IPOJul 27, 2023
Series CJun 24, 2021
Series BMar 1, 2020

Key People

Founding team and executive leadership

Aurél Prósz

CTO and Founder

Founding Team

Bogumil Zimon

CEO & Founder

Founding Team

PharosBio Investors

Notable investors and investment history

PharosBio investors
InvestorRounds
KDB Capital CorpSeries C
DSC InvestmentSeries A, Series B, Convertible Debt
UTC InvestmentSeries C
Korea Investment PartnersSeries A, Series B, Convertible Debt
Timefolio Asset ManagementSeries C
Company K PartnersSeries C, Series B, Convertible Debt
LSK InvestmentSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 22, 2025

    $13M raised from Korea Investment & Securities and others.

  • Jun 24, 2021

    $16M round with participation from KDB Capital Corp and Timefolio Asset Management.

PharosBio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PharosBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PharosBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen
Employee Range4
Year Founded2024
Last FundingDec 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.